Rivorca, containing the active ingredient Voriconazole, is an antifungal medication used to treat serious fungal infections. It is particularly effective against infections caused by Aspergillus and Candida species.
Rivorca works by inhibiting the synthesis of ergosterol, an essential component of fungal cell membranes. This disruption leads to increased cell membrane permeability and ultimately results in cell death.
Rivorca is indicated for the treatment of various fungal infections, including:
Rivorca is typically administered orally or intravenously, depending on the severity of the infection and the patient's condition. Dosage will be determined by a healthcare professional based on individual needs.
Common side effects may include:
Serious side effects can occur, and patients should contact their healthcare provider if they experience symptoms such as liver problems or severe skin reactions.
Rivorca is contraindicated in patients with known hypersensitivity to Voriconazole or any of its components. Caution is advised in patients with liver dysfunction or those taking certain medications that may interact with Rivorca.
Before starting Rivorca, inform your healthcare provider about:
Rivorca (Voriconazole) is a vital medication in the fight against serious fungal infections. Understanding its use, administration, and potential side effects can help ensure effective treatment and safety.